Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Exchange Rate Effect (2019 - 2025)

TELA Bio has reported Exchange Rate Effect over the past 7 years, most recently at -$35000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$35000.0 for Q4 2025, down 119.23% from a year ago — trailing twelve months through Dec 2025 was -$217000.0 (down 875.0% YoY), and the annual figure for FY2025 was -$217000.0, down 875.0%.
  • Exchange Rate Effect for Q4 2025 was -$35000.0 at TELA Bio, down from $104000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for TELA hit a ceiling of $182000.0 in Q4 2024 and a floor of -$188000.0 in Q3 2024.
  • Median Exchange Rate Effect over the past 5 years was -$500.0 (2021), compared with a mean of -$7900.0.
  • Peak annual rise in Exchange Rate Effect hit 2150.0% in 2022, while the deepest fall reached 5400.0% in 2022.
  • TELA Bio's Exchange Rate Effect stood at -$2000.0 in 2021, then surged by 2150.0% to $41000.0 in 2022, then crashed by 65.85% to $14000.0 in 2023, then surged by 1200.0% to $182000.0 in 2024, then crashed by 119.23% to -$35000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$35000.0 (Q4 2025), $104000.0 (Q3 2025), and -$152000.0 (Q2 2025) per Business Quant data.